SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,514.04 |
| Enterprise Value ($M) | 4,593.38 |
| Book Value ($M) | 1,655.08 |
| Book Value / Share | 33.16 |
| Price / Book | 2.12 |
| NCAV ($M) | -1,288.29 |
| NCAV / Share | -25.81 |
| Price / NCAV | -2.73 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.07 |
| Return on Assets (ROA) | 0.06 |
| Return on Equity (ROE) | 0.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.02 |
| Current Ratio | 3.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 375.04 |
| Assets | 3,318.42 |
| Liabilities | 1,663.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1,125.36 |
| Operating Income | 342.43 |
| Net Income | 209.34 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 248.93 |
| Cash from Investing | -20.11 |
| Cash from Financing | -241.01 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Macquarie Group Ltd | 6.17 | ||
| 13G | Ariel Investments, Llc | |||
| 13G/A | Vanguard Group Inc | 11.60 | 0.13 | |
| 13G/A | Dimensional Fund Advisors Lp | 6.90 | -6.54 | |
| 13G/A | BlackRock Inc. | 18.30 | -3.61 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,962 | 163,052 | 10.40 | |
| 24,258 | 188,240 | 12.89 | |
| 25,450 | 228,521 | 11.14 | |
| 20,974 | 163,035 | 12.86 | |
| 23,031 | 137,855 | 16.71 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MRK – Merck & Co., Inc. | NUVB – Nuvation Bio Inc. |
| OGN – Organon & Co. | PFE – Pfizer Inc. |
| PRGO – Perrigo Company plc |
Financial data and stock pages provided by
Fintel.io